AI Fund Makes First Investment in India, Backs Healthcare Startup Jivi: Report

AI Fund Makes First Investment in India, Backs Healthcare Startup Jivi
AI Fund, led by computer scientist Andrew Ng, has made its first investment in India by backing Gurugram-based artificial intelligence (AI) healthcare startup Jivi. The amount of the investment was not disclosed, according to a Reuters report.

  • Make Telecom Talk My Trusted Source
  • Source of Google
  • Source of Google

Also Read: Google and Vodafone Expand Partnership to Bring AI-Powered Services Across Europe and Africa

AI-Powered Healthcare Innovations

Jivi uses AI to assist in diagnosing conditions, suggesting treatments, generating health reports, and performing administrative tasks, the fund said in a statement, according to the report. This move comes as India’s AI sector is expected to grow to over USD 22 billion by 2027, according to a Nasscom-BCG report released earlier this year. Within this growth, AI-based products and startups are expected to play a significant role, potentially accounting for 15-17 percent of the market.

Backed by Sequoia Capital and SoftBank Group, AI Fund has also invested in the podcast-production platform Podcastle and the investment-research application Octagon AI.

Reportedly, Andrew Ng, managing general partner at AI Fund, who previously led AI projects at Google and Baidu, joined Amazon’s board in April.

Also Read: AI to Transform Global Economy with Growth and Innovation, Says UBS: Report

Introduces Jivi-RadX-v1

On October 5, Jivi AI Co-Founder and CEO Ankur Jain announced the introduction of Jivi-RadX-v1, Jivi’s latest vision-based LLM model. “Built to assist radiologists in making faster, more accurate decisions, Jivi-RadX dives deep into complex image data, delivering sharper insights like never before,” Ankur said in a LinkedIn post.

“Jivi-RadX is one of the top-performing models, scoring an impressive 75 percent and surpassing OpenAI’s GPT-4 as well as other state-of-the-art models like Microsoft’s Llava-Med and Stanford’s ChexAgent-8b,” he added.

If this article saved you time or helped you decide better, consider supporting our work.